5 mg/2.5 mg Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule Blister (Blister)
Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 60687-639
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 60687-639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
5 mg/2.5 mg Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsules Carton (Carton)
Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP is a medication that comes in a 20-capsule container with each capsule containing 5 mg of chlordiazepoxide HOI and 2.5 mg of clidinium bromide. This medication is a DEA exempt product that can be used as directed by a physician, taking one or two capsules 3 or 4 times daily before meals or bedtime. Additional information regarding dosage recommendations and full prescribing information can be found in the package insert. The medication should be stored within a temperature range of 20-25°C (68-77°F), with occasional excursions permitted between 15-30°C (59-86°F). This medication is distributed by American Health Packaging in Columbus, Ohio.*
Chlordiazepoxide Hydrochloride Structural Formula (Chlordiazepoxide Structure)
Clidinium Bromide Structural Formula (Clidinium Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
